RESPONSE TO ERYTHROPOIETIN THERAPY AND ITS RELATION TO THE PRESENCE OF ANTI-ERYTHROPIOETIN ANTIBODIES IN PEDIATRIC PATEINTS ON REGULAR HEAMODIALYSIS
• 2016
Publication Information
Authors
Ashraf Hamed EI- Shukary, Mohammad Sabry Seleam , Fatena Ibraheem Fadel, Osama Zaki Ahmad, Mona Aziz Ibraheem.
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Anemia develops early in the course of renal failure, becomes
prominent as the disease progress, and contributes substantially to
disability. Patients with renal failure have lower plasma levels of
erythropoietin and less erythropoiesis than other patients with similar
degree of anemia, suggesting inadequate production of erythropoietin by
the diseased kidney as the primary mechanism of renal anemia
prominent as the disease progress, and contributes substantially to
disability. Patients with renal failure have lower plasma levels of
erythropoietin and less erythropoiesis than other patients with similar
degree of anemia, suggesting inadequate production of erythropoietin by
the diseased kidney as the primary mechanism of renal anemia
Staff Members - Benha University